Press Release: Eos acquires minority in pharma repackager

September 2, 2016

Eos Capital partners with Namibian Pharmaceutical manufacturer to establish major regional pharma player Eos Capital is pleased to announce that it has acquired 35% of the ordinary share capital of Fabupharm (Pty) Ltd, pending Namibian Competition Commission approval, with the aim of supporting Fabupharm in its ambition to become a major player in the Namibian…

Read More